New Key Statistics Module, Z-Score and F-Score
OTCPK:DIUXF Key Ratios
| Market Cap $ M | 150.59 |
| Enterprise Value $ M | 132.04 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 54.69 |
| Price/Book | 3.17 |
| Price/Sales | 4.69 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 33.00 |
| EPS (TTM) $ | -0.04 |
| Beneish M-Score | -2.65 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 17.40 |
| y-y EBITDA Growth Rate % | -57.50 |
| EV-to-EBIT | -29.06 |
| EV-to-EBITDA | 75.61 |
| PEG | -- |
| Shares Outstanding M | 84.52 |
| Net Margin (%) | -10.90 |
| Operating Margin % | -17.00 |
| Pre-tax Margin (%) | -14.36 |
| Quick Ratio | 4.85 |
| Current Ratio | 4.85 |
| ROA % (ttm) | -6.19 |
| ROE % (ttm) | -7.08 |
| ROIC % (ttm) | -12.18 |
| Dividend Yield % | -- |
| Altman Z-Score | 14.35 |
DIUXF Number of Guru Trades
DIUXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:DIUXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DIUXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Diaceutics PLC Insider Transactions
No Available Data
News about OTCPK:DIUXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers